We are live on ! Find out more
IBBQ icon

Invesco NASDAQ Biotechnology ETF

32 hedge funds and large institutions have $20.4M invested in Invesco NASDAQ Biotechnology ETF in 2025 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,569% more capital inflows, than outflows

Capital inflows: $11M | Capital outflows: $662K

200% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 6

60% more funds holding

Funds holding: 20 → 32 (+12)

11.01% more ownership

Funds ownership: 21.62% → 32.63% (+11%)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

Holders
32
Holders Change
+12
Holders Change %
+60%
% of All Funds
0.39%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
18
Increased
3
Reduced
3
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

IBBQ Hedge Fund Activity: Q4 2025 in Review

32 of the 8,300 institutional investors tracked by Wall St. Rank reported a position in Invesco NASDAQ Biotechnology ETF (IBBQ) for Q4 2025, worth a combined $20.4M — up 149% from $8.2M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new IBBQ positions and 6 closed out — a net gain of 12 holders — while 3 added to existing stakes and 3 trimmed.

The largest buyer was Raymond James Financial, opening a new position worth an estimated $2.83M. The largest seller was GeoWealth Management, cutting an estimated $424K.

  • 32 institutional investors held Invesco NASDAQ Biotechnology ETF (IBBQ) as of Q4 2025, up from 20 in Q3 2025.
  • Funds reported $20.4M of Invesco NASDAQ Biotechnology ETF stock for Q4 2025, up 149% quarter-over-quarter.
  • 18 funds opened new Invesco NASDAQ Biotechnology ETF positions in Q4 2025 and 6 closed out, a net change of +12 holders.
  • The largest Invesco NASDAQ Biotechnology ETF buyer in Q4 2025 was Raymond James Financial, an estimated $2.83M added.
  • The largest Invesco NASDAQ Biotechnology ETF seller in Q4 2025 was GeoWealth Management, an estimated $424K sold.

Based on aggregated 13F filings for Q4 2025.